Boston Scientific Corp. (BSX)
41.98
-1.01
(-2.35%)
USD |
NYSE |
Nov 20, 16:00
42.15
+0.17
(+0.40%)
After-Hours: 20:00
Boston Scientific Research and Development Expense (TTM) : 2.159B for Sept. 30, 2026
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| September 30, 2026 | 2.159B |
| June 30, 2026 | 2.153B |
| March 31, 2026 | 2.125B |
| December 31, 2025 | 2.052B |
| September 30, 2025 | 1.943B |
| June 30, 2025 | 1.836B |
| March 31, 2025 | 1.693B |
| December 31, 2024 | 1.616B |
| September 30, 2024 | 1.519B |
| June 30, 2024 | 1.468B |
| March 31, 2024 | 1.444B |
| December 31, 2023 | 1.415B |
| September 30, 2023 | 1.382B |
| June 30, 2023 | 1.365B |
| March 31, 2023 | 1.341B |
| December 31, 2022 | 1.323B |
| September 30, 2022 | 1.313B |
| June 30, 2022 | 1.284B |
| March 31, 2022 | 1.247B |
| December 31, 2021 | 1.204B |
| September 30, 2021 | 1.17B |
| June 30, 2021 | 1.175B |
| March 31, 2021 | 1.119B |
| December 31, 2020 | 1.143B |
| September 30, 2020 | 1.166B |
| Date | Value |
|---|---|
| June 30, 2020 | 1.157B |
| March 31, 2020 | 1.195B |
| December 31, 2019 | 1.175B |
| September 30, 2019 | 1.154B |
| June 30, 2019 | 1.137B |
| March 31, 2019 | 1.132B |
| December 31, 2018 | 1.113B |
| September 30, 2018 | 1.089B |
| June 30, 2018 | 1.054B |
| March 31, 2018 | 1.023B |
| December 31, 2017 | 997.00M |
| September 30, 2017 | 989.00M |
| June 30, 2017 | 967.00M |
| March 31, 2017 | 945.00M |
| December 31, 2016 | 920.00M |
| September 30, 2016 | 908.00M |
| June 30, 2016 | 897.00M |
| March 31, 2016 | 895.00M |
| December 31, 2015 | 877.00M |
| September 30, 2015 | 841.00M |
| June 30, 2015 | 832.00M |
| March 31, 2015 | 818.00M |
| December 31, 2014 | 817.00M |
| September 30, 2014 | 826.00M |
| June 30, 2014 | 831.00M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Abbott Laboratories | 3.30B |
| Becton, Dickinson & Co. | 1.059B |
| Stryker Corp. | 1.625B |
| Insulet Corp. | 360.30M |
| Intuitive Surgical, Inc. | 1.493B |